Selective Serotonin Reuptake Inhibitors may Influence COVID-19 Prognosis through Antioxidant and Cytoprotective Pathways Mediated by Sigma 1 Receptor Agonism.
Konstantinos I PapadopoulosAlexandra PapadopoulouTar-Choon AwPublished in: Pharmacopsychiatry (2022)